Event Newsletter
FUSE-AI
- Medical Technology/Devices/Equipment
- AI
![](https://chambermaster.blob.core.windows.net/images/customers/2968/members/5225/logos/MEMBER_PAGE_HEADER/Prostate_monitor_V3.jpg)
-
About
We focus on Artificial Intelligence in diagnostic medicine and personalised medicine.
1. We develop intelligent tools for radiologists to detect lesions in MRI images faster and more safely for various indications - for prostate-, breast-, lung-cancer e.c..
2. We are involved in research projects with renowned university hospitals. We develop new AI Solutions for Robotic in Healthcare.
3. We are listed as a medical device manufacturer in Europe with the Federal Institute for Drugs and Medical Devices (BfArM). We are certified according to 13485.
We received the MDR II a certification for our product Prostate.Carcinoma.ai on 15.12.2023.
We will get the FDA approval in Q4
Challenge: The analysis of multiparametric MRIs (mpMRI) of the prostate is time consuming (>20 min), prone to error (false-positive-rate 14%) and the quality of findings depends to a large degree on the radiologist’s experience. Unnecessary treatment and the consequential complications as well as too-late recognition of tumours and reduced chances of a successful treatment process are the results of these false diagnoses.
Solution and customer benefit: Our software ProstateCarcinoma.ai is based on artificial neural networks. The software gives an independent second opinion on the detection of abnormalities, generates markers, conducts measurements.
-
Whom to Contact
- Mr. Matthias Marianus SteffenCEO & FounderGroßer Burstah 46-48Hamburg, 20457Phone: +49 171 269-0328
- Maximilian Waschka
-
-
Directions
Near by the Town hall